LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,400 | 6,310 | 6,480 | 8,560 | 11,170 |
| Marketable Securities | 6,990 | 7,840 | 11,350 | 12,460 | 12,170 |
| Other current assets | 470 | 280 | 630 | 450 | 520 |
| TOTAL | $11,860 | $14,430 | $18,460 | $21,470 | $23,860 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,510 | 1,500 | 1,440 | 1,430 | 1,280 |
| TOTAL | $1,510 | $1,500 | $1,440 | $1,430 | $1,280 |
| Total Assets | $14,040 | $16,670 | $20,470 | $23,800 | $25,810 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 220 | 50 | 220 | 330 | 1,250 |
| Accrued Expenses | 780 | 1,100 | 1,090 | 1,180 | 930 |
| Other current liabilities | 0 | 0 | 1,640 | 2,320 | 1,760 |
| TOTAL | $1,200 | $1,350 | $3,060 | $3,930 | $3,950 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 40 | 0 | 0 | 0 | 0 |
| TOTAL | $40 | $90 | $60 | $90 | $N/A |
| Total Liabilities | $1,250 | $1,450 | $3,120 | $4,020 | $3,950 |
| Shareholders' Equity | |||||
| Common Shares | 200 | 200 | 200 | 200 | 200 |
| Retained earnings | -71,760 | -69,290 | -67,170 | -64,710 | -62,610 |
| Other shareholders' equity | 0 | -10 | -10 | 0 | -10 |
| TOTAL | $12,790 | $15,220 | $17,340 | $19,770 | $21,850 |
| Total Liabilities And Equity | $14,040 | $16,670 | $20,460 | $23,790 | $25,800 |